Understanding Lung Problems in WTC Survivors
Complex WTC Exposures Impacting Persistent Large and Small Airflow Limitation and Vulnerable Subgroups in the WTC Survivor Population
This project looks closely at how World Trade Center exposures affect breathing problems in survivors, especially those with severe or long-lasting symptoms.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11074513 on NIH RePORTER |
What this research studies
Many World Trade Center (WTC) survivors still experience breathing difficulties and lung problems more than 20 years after the 9/11 attacks. This project aims to understand why some survivors have more severe or persistent airflow limitations in their lungs. Researchers will use detailed lung function tests, including those after bronchodilator medication, to identify specific patterns of lung injury. The goal is to uncover how WTC exposures and other health conditions contribute to these breathing issues, particularly in different groups of survivors.
Who could benefit from this research
Good fit: This project focuses on World Trade Center survivors who experience ongoing breathing problems and lung function abnormalities.
Not a fit: Patients who were not exposed to the World Trade Center events or do not have related respiratory issues would not directly benefit from this specific research.
Why it matters
Potential benefit: This work could lead to a better understanding of severe and persistent lung disease in WTC survivors, potentially guiding more targeted care and support for those most affected.
How similar studies have performed: Previous work has identified general lung function issues in WTC survivors, but this project offers a novel, more detailed look at severe and persistent airflow limitations and vulnerable subgroups.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Liu, Mengling — New York University School of Medicine
- Study coordinator: Liu, Mengling
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.